Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.116329
Table 3 Clinicopathological assessment
| Comparison | P value (χ2) |
| PNI (+) vs margin status | 0.028 |
| PNI (+) vs resection type (R0 vs R1/R2) | 0.041 |
| PNI (+) vs T stage (T1-T4) | 0.033 |
| Margin status vs recurrence | 0.046 |
| T stage vs recurrence | 0.021 |
| T stage vs metastasis (M stage) | 0.037 |
| N stage vs recurrence | 0.38 |
| N stage vs metastasis | 0.44 |
| Tumor location vs PNI | 0.048 |
| Tumor location vs recurrence | 0.048 |
| Solid subtype vs recurrence | 0.031 |
| Solid subtype vs disease-related death | 0.045 |
- Citation: Stawarz K, Gorzelnik A, Klos W, Korzon J, Kissin F, Bienkowska-Pluta K, Stawarz G, Rusetska N, Zwoliński J. Prognostic value of clinicopathological parameters in adenoid cystic carcinoma: A retrospective cohort study. World J Clin Oncol 2026; 17(4): 116329
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/116329.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.116329